For STEC O26:H11, stx1a was observed to predominate in all STEC O26:H11 cases (59%) and but not in severe illness (50%), nor HUS (11%); and stx2a predominated in HUS cases (89%) (Figure 7B). This evidence concerns the gene STX1A and hemolytic-uremic syndrome.